Conflicts of interest Dr Strober is a consultant (honoraria) for AbbVie, Alumis, Almirall, Amgen, Apogee, Arcutis, Boehringer Ingelheim, Bristol-Myers-Squibb, Capital One, CorEvitas, Dermavant, Immunovant, Janssen, Leo, Eli Lilly, Maruho, Oruka, Meiji Seika Pharma, Protagonist, Takeda, Novartis, Pfizer, UCB Pharma, Rapt, Regeneron, Sanofi-Genzyme, and Union Therapeutics. Owns stock options in Connect Biopharma and Mindera Health. They are a speaker for AbbVie, Arcutis, Dermavant, Eli Lilly, Incyte, Janssen, Regeneron, Sanofi-Genzyme. Receives consulting fees as a Scientific Co-Director from CorEvitas Psoriasis Registry. They are an Investigator for CorEvitas Psoriasis Registry. There are an Editor-in-Chief (honorarium) for the Journal of Psoriasis and Psoriatic Arthritis. Dr Blauvelt has served as a speaker (received honoraria) for Eli Lilly and Company, UCB, and Almirall, has served as a scientific adviser (received honoraria) for AbbVie, Almirall, Alumis, Amgen, Anaptysbio, Apogee, Arcutis, Astria, Boehringer Ingelheim, Bristol Myers Squibb, Celltrion, Corvus, Dermavant, Eli Lilly and Company, Galderma, GlaxoSmithKline, Immunovant, Incyte, IQVIA, Janssen, Leo, Lipidio, Merck, Novartis, Oruka, Paragon, Pfizer, Rani Therapeutics, Regeneron, Sanofi, Spherix Global Insights, Sun Pharma, Syncona, Takeda, UCB, Union, and Zai Lab, has acted as a clinical study investigator (institution has received clinical study funds) for AbbVie, Acelyrin, Almirall, Alumis, Amgen, Arcutis, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Galderma, Incyte, Janssen, Leo, Merck, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, and UCB, and owns stock in Lipidio and Oruka. Dr Kerkhof has received fees for consultancy services or lectureships from Almirall, Eli Lilly, Novartis, Janssen Pharmaceutical, Bristol-Myers Squibb, UCB, Boehringer Ingelheim, Centrion, and Sandoz. Dr Asawanonda has received honoraria as a speaker from Boehringer Ingelheim, Eli Lilly, Novartis, Janssen, LEO Pharma, Pfizer, Sanofi, Kyowa Kirin, Beiersdorf, and LaRoche Posay. For consultancy or advisory board from Boehringer Ingelheim, Eli Lilly, Novartis, Janssen, LEO Pharma, Pfizer, Sanofi, Kyowa Kirin, Beiersdorf, and LaRoche Posay. As Investigator consultant from Boehringer Ingelheim, Eli Lilly, Novartis, LEO Pharma, Kyowa Kirin, GSK, and Beiersdorf. Dr Chandra has no conflicts of interest to declare. Dr González-Cantero has served as a consultant for and received speaker fees from AbbVie, Janssen, Amgen, Novartis, Almirall, Boehringer Ingelheim, Celgene, BMS, UCB, L'Oreal, MSD, and Leo Pharma. Dr Gonzalez has served as a consultant for and received speaker fees from AbbVie, Janssen, Novartis, Eli Lilly, L'Oreal, and Boehringer Ingelheim. Dr Matlock has served as a consultant for and received speaker fees from AbbVie, Janssen, Novartis, Pfizer, L'Oreal, Leo Pharma, Merck Sharp and Dome, Glaxo Wellcome, SmithKline Beecham, and Sanofi. Dr Maul has served as advisor and/or received speaking fees and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, BMS, Celgene, Eli Lilly, Incyte, Janssen-Cilag, LEO Pharma, MSD, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi, Takeda, and UCB. Dr Rob has received honoraria as a speaker and/or consultant for AbbVie, Almirall, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Johnson and Johnson, Leo Pharma, Novartis, MSD, Pfizer, Sanofi Genzyme, and UCB. Dr Torres has received consultancy and/or speaker's honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Apogee Therapeutics, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Johnson & Johnson Innovative Medicine, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz, STADA, and UCB. Dr Skov has received research funding from Almirall, UCB, Sanofi, Bristol-Myers Squibb, Janssen, the Danish National Psoriasis Foundation, the LEO Foundation, and the Kgl. Hofbundtmager Aage Bang Foundation and honoraria as consultant and/or speaker for AbbVie, Eli Lilly, Novartis, Pfizer, LEO Pharma, Bristol-Myers Squibb, Janssen, UCB, Almirall, Galderma, Takeda, Stada, and Sanofi.